Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
294 |
issn |
0920-1211 |
issueIdentifier |
3 |
pageRange |
286-294 |
publicationName |
Epilepsy Research |
startingPage |
286 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4f04ce88ae39f157e58131f17d961fe6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2820c36905778e8beb7b26960110cf4c |
bibliographicCitation |
Hartman AL. Neuroprotection in metabolism-based therapy. Epilepsy Research. 2012 Jul;100(3):286–94. doi: 10.1016/j.eplepsyres.2011.04.016. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f01b99cfcd2c0e26dde289e5133bb58b |
date |
201207 |
identifier |
https://doi.org/10.1016/j.eplepsyres.2011.04.016 https://pubmed.ncbi.nlm.nih.gov/21872441 https://pubmed.ncbi.nlm.nih.gov/PMC3245363 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Neuroprotection in metabolism-based therapy |
discusses |
http://id.nlm.nih.gov/mesh/M0028008 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D019636Q000178 http://id.nlm.nih.gov/mesh/D010300Q000178 http://id.nlm.nih.gov/mesh/D055423 http://id.nlm.nih.gov/mesh/D031204 http://id.nlm.nih.gov/mesh/D000544Q000178 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018696Q000627 http://id.nlm.nih.gov/mesh/D000818 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10721 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9643 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 |